No other therapy area attracts more attention or is more hotly pursued by researchers than cancer. Latest developments in gene therapy have given real hope for radical therapies, and the potential commercial awards for industry ensure interest and investment remains high.
The World Cancer Market Yearbook 2005 is an essential reference for everyone working in or with the cancer industry. In over 425 information-rich pages, the report looks at the major research sectors of the cancer market, and readily answers thousands of key commercial and research questions such as:

Which country has the highest rate of lung cancer?
What is the biggest-selling drug for breast cancer?
What drugs for treating prostate cancer are in Phase III trials?
Which companies have struck up cancer development agreements in 2005?
What potential GI cancer drugs does MGI Pharma have in Phase II?

The report is divided into chapters for specific leading cancer types:
Lung
Breast
Colorectal
Genito-urinary (prostate, renal, bladder)
Gastrointestinal
Ovarian

Each chapter contains:
Cancer Description & Background;
Market Information - Morbidity/mortality/prevalence/projected prevalence (numbers and rates per 100,000 population);
Drugs on the Market- Branded and generic products with monographs and sales figures, where available;
Ongoing R&D - Drugs in the pipeline;
Who's Working with Whom? - Significant strategic alliances since January 2005 presented by month;
Major Events - Notable company and product events since January 2005 presented by month.